Michael S. Biggers

487 total citations
15 papers, 402 citations indexed

About

Michael S. Biggers is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Michael S. Biggers has authored 15 papers receiving a total of 402 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Organic Chemistry, 7 papers in Molecular Biology and 4 papers in Pharmacology. Recurrent topics in Michael S. Biggers's work include Chemical Synthesis and Analysis (3 papers), Asymmetric Synthesis and Catalysis (3 papers) and Synthesis of Organic Compounds (3 papers). Michael S. Biggers is often cited by papers focused on Chemical Synthesis and Analysis (3 papers), Asymmetric Synthesis and Catalysis (3 papers) and Synthesis of Organic Compounds (3 papers). Michael S. Biggers collaborates with scholars based in United States. Michael S. Biggers's co-authors include Kevin M. Koch, Robert Chambers, John B. Cheng, Kelvin Cooper, Kenneth G. Kraus, Robert J. Mather, David B. Damon, Carol Donovan, Anthony Marfat and Hiroko Masamune and has published in prestigious journals such as Journal of Medicinal Chemistry, The Journal of Organic Chemistry and Molecular Pharmacology.

In The Last Decade

Michael S. Biggers

14 papers receiving 368 citations

Peers

Countries citing papers authored by Michael S. Biggers

Since Specialization

Citations

This map shows the geographic impact of Michael S. Biggers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael S. Biggers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael S. Biggers more than expected).

Fields of papers citing papers by Michael S. Biggers

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael S. Biggers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael S. Biggers. The network helps show where Michael S. Biggers may publish in the future.

Co-authorship network of co-authors of Michael S. Biggers

This figure shows the co-authorship network connecting the top 25 collaborators of Michael S. Biggers. A scholar is included among the top collaborators of Michael S. Biggers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael S. Biggers. Michael S. Biggers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Synthesis of (+)- and (−)-Tetrabenazine from the Resolution of α-Dihydrotetrabenazine 2009 ·Synthetic Communications ·(unknown), Michael S. Biggers, (unknown), George A. Brine, (unknown)	13
2	trans-3-Benzyl-4-hydroxy-7-chromanylbenzoic acid derivatives as antagonists of the leukotriene B4 (LTB4) receptor 1998 ·Bioorganic & Medicinal Chemistry Letters ·Lawrence A. Reiter, Kevin M. Koch, Anthony D. Piscopio, Henry J. Showell, (unknown), Michael S. Biggers, Robert Chambers, Maryrose J. Conklyn, Kelvin Cooper, (unknown), Joseph DiBrino, Beryl W. Dominy, Cathy A. Farrell, Gary P. Hingorani, (unknown), (unknown), (unknown)	11
3	Synthetic approaches to 2-(4-hydroxy-7-chromanyl)benzoic acids as antagonists of leukotriene B4 1998 ·Bioorganic & Medicinal Chemistry Letters ·Robert Chambers, Kevin M. Koch, Michael S. Biggers, (unknown)	3
4	The SAR of UK-78,282: A novel blocker of human T cell Kv1.3 potassium channels 1997 ·Bioorganic & Medicinal Chemistry Letters ·Laurence E. Burgess, Kevin M. Koch, Kelvin Cooper, Michael S. Biggers, (unknown), Jacqueline H. Smitrovich, Eric J. Gilbert, (unknown), Robert J. Mather, Carol Donovan, Douglas C. Hanson	17
5	3-Substituted-4-hydroxy-7-chromanylacetic acid derivatives as antagonists of the leukotriene B4 (LTB4) receptor 1997 ·Bioorganic & Medicinal Chemistry Letters ·Lawrence A. Reiter, Lawrence S. Melvin, (unknown), Henry J. Showell, Kevin M. Koch, Michael S. Biggers, John B. Cheng, R Breslow, Maryrose J. Conklyn, Cathy A. Farrell, (unknown), Ellen R. Laird, John J. Martin, (unknown), (unknown)	7
6	Novel nonpeptide agents potently block the C-type inactivated conformation of Kv1.3 and suppress T cell activation. 1996 ·Molecular Pharmacology ·Angela Nguyen, John C. Kath, Douglas C. Hanson, Michael S. Biggers, Paul C. Canniff, Carol Donovan, Robert J. Mather, (unknown), Heiko Rauer, Jayashree Aiyar, A. Lepple-Wienhues, George A. Gutman, Stephan Grissmer, Michael D. Cahalan, K. George Chandy	93
7	Biarylcarboxylic Acids and -amides: Inhibition of Phosphodiesterase Type IV versus [³H]Rolipram Binding Activity and Their Relationship to Emetic Behavior in the Ferret 1996 ·Journal of Medicinal Chemistry ·Allen J. Duplantier, Michael S. Biggers, Robert Chambers, John B. Cheng, Kelvin Cooper, David B. Damon, James F. Eggler, Kenneth G. Kraus, Anthony Marfat, Hiroko Masamune, (unknown), (unknown), John P. Umland, J. W. Watson	116
8	The C-32 Triacetyl-L-rhamnose Derivative of Ascomycin: A Potent, Orally Active Macrolactone Immunosuppressant 1995 ·Journal of Medicinal Chemistry ·Kevin M. Koch, M F Newborg, Douglas C. Hanson, Kelvin Cooper, Richard M. Shepard, Michael Biehl, Michael S. Biggers, (unknown), Gary R. Schulte	3
9	(+)-1-(3S,4R)-[3-(4-Phenylbenzyl)-4- hydroxychroman-7-yl]cyclopentane Carboxylic Acid, a Highly Potent, Selective Leukotriene B4 Antagonist with Oral Activity in the Murine Collagen-Induced Arthritis Model 1994 ·Journal of Medicinal Chemistry ·Kevin M. Koch, Lawrence S. Melvin, Lawrence A. Reiter, Michael S. Biggers, Henry J. Showell, R. Griffiths, E. R. Pettipher, John B. Cheng, Anthony J. Milici	48
10	General Preparation of 7-Substituted 4-Chromanones: Synthesis of a Potent Aldose Reductase Inhibitor 1994 ·The Journal of Organic Chemistry ·Kevin M. Koch, Michael S. Biggers	36
11	A Direct Synthesis of Pharmacologically Activeortho-Substituted Biaryls: A Combined Directed Metalation-Palladium Catalyzed Cross Coupling Approach Using Aryl Oxazolines or Benzamides 1994 ·Synlett ·Kevin M. Koch, Robert Chambers, Michael S. Biggers	13
12	Manganese(III)-promoted oxidative free-radical cyclizations of β-keto imides: Asymmetric induction with oppolzer's chiral sultam 1992 ·Tetrahedron Letters ·(unknown), (unknown), Christopher K. Bíggers, Michael S. Biggers, (unknown), Donald G. Davis	36
13	Aldol Condensation: A Stereoselective Approach to Tetrahydrophenanthrene Derivatives and 3-Oxa-bicyclo[3.3.1]nonan-6-ones 1991 ·Synthetic Communications ·P. A. ZORETIC, Michael S. Biggers, Christopher K. Bíggers, (unknown)	0
14	A stereoselective synthesis of d,l-16-oxa-15.alpha.-methyl-19-nortestosterone 1990 ·The Journal of Organic Chemistry ·P. A. ZORETIC, (unknown), Michael S. Biggers, (unknown)	3
15	A Stereooontrolled Approach to Tri and Tetrasubstttuted Cyclohexanones 1989 ·Synthetic Communications ·P. A. ZORETIC, Scott H. Dickerson, (unknown), Michael S. Biggers, Robert Chambers, Christopher K. Bíggers, (unknown)	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact